RecruitingNCT01762813

Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer

Prospective, Population-based Cohort Collection of Blood Samples and Tumor Tissue From Patients Operated on for Primary or Metastatic Colorectal Cancer


Sponsor

Helse Stavanger HF

Enrollment

1,200 participants

Start Date

Jan 1, 2013

Study Type

OBSERVATIONAL

Conditions

Summary

* A prospective, observational study on clinical outcomes of surgical management of primary and metastatic colorectal cancer * Prospective collection of tissues to explore potential biomarkers in blood and/or primary or secondary cancers and/or normal colon


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study collects detailed health information and tissue samples from people with colorectal cancer (bowel cancer) before and after surgery, to help researchers understand which biological markers can predict treatment outcomes. **You may be eligible if...** - You have been diagnosed with colorectal cancer (either the original tumor or cancer spread to the liver), and surgery is planned with the goal of curing the disease - You are 18 years of age or older - You are willing and able to give informed consent **You may NOT be eligible if...** - You are unable or unwilling to provide written informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREopen and laparoscopic surgery

Curative surgery for either primary (colorectal cancer, crc) or metastatic CRC (liver surgery)


Locations(1)

Stavanger University Hospital

Stavanger, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01762813


Related Trials